Our hypothesis is that a cell free protein toxin plays a critical role in pathogenesis of Shigella infections. The toxin may be responsible for both clinical manifestations of the disease, watery diarrhea and dysentery. A basic understanding of the mechanisms by which the toxin mediates its biological effects will aid in the development of improved therapeutic treatment programs and of safe and effective vaccine strains. To study the mechanism of action of Shigella toxin we will investigate toxin mediated inhibition of protein synthesis. Using a cell free system we will determine specifically what biochemical step in protein synthesis is inhibited by the toxin. We will employ various methods for protein and RNA separation and characterization to investigate the actual toxin catalyzed ribosomal alteration which leads to the protein synthesis inhibition. Using both in vivo and in vitro systems we will determine whether toxin inhibits protein synthesis in the lumen of the small intestine. By using cell separation techniques, the effects of toxin on the various cell components of the intestinal lumen will be determined. Finally by separating A and B chains and by using monoclonal antibodies directed against the toxin chains we will investigate the role of these chains in the various biological activities of the toxin. In addition to clarifying the role of toxin in pathogenesis, these studies should also provide some basic information concerning the structure and function of the eukaryotic ribosome.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI020325-02
Application #
3129920
Study Section
Bacteriology and Mycology Subcommittee 1 (BM)
Project Start
1984-04-01
Project End
1987-03-31
Budget Start
1985-04-01
Budget End
1986-03-31
Support Year
2
Fiscal Year
1985
Total Cost
Indirect Cost
Name
Tufts University
Department
Type
Schools of Medicine
DUNS #
604483045
City
Boston
State
MA
Country
United States
Zip Code
Fuchs, S; Muhldorfer, I; Donohue-Rolfe, A et al. (1999) Influence of RecA on in vivo virulence and Shiga toxin 2 production in Escherichia coli pathogens. Microb Pathog 27:13-23
Gunzer, F; Bohn, U; Fuchs, S et al. (1998) Construction and characterization of an isogenic slt-ii deletion mutant of enterohemorrhagic Escherichia coli. Infect Immun 66:2337-41
Muhldorfer, I; Hacker, J; Keusch, G T et al. (1996) Regulation of the Shiga-like toxin II operon in Escherichia coli. Infect Immun 64:495-502
Tzipori, S; Gunzer, F; Donnenberg, M S et al. (1995) The role of the eaeA gene in diarrhea and neurological complications in a gnotobiotic piglet model of enterohemorrhagic Escherichia coli infection. Infect Immun 63:3621-7
Acheson, D W; De Breucker, S A; Jacewicz, M et al. (1995) Expression and purification of Shiga-like toxin II B subunits. Infect Immun 63:301-8
Donta, S T; Tomicic, T K; Donohue-Rolfe, A (1995) Inhibition of Shiga-like toxins by brefeldin A. J Infect Dis 171:721-4
Jacewicz, M S; Acheson, D W; Mobassaleh, M et al. (1995) Maturational regulation of globotriaosylceramide, the Shiga-like toxin 1 receptor, in cultured human gut epithelial cells. J Clin Invest 96:1328-35
Keusch, G T; Jacewicz, M; Acheson, D W et al. (1995) Globotriaosylceramide, Gb3, is an alternative functional receptor for Shiga-like toxin 2e. Infect Immun 63:1138-41
Acheson, D W; Jacewicz, M; Kane, A V et al. (1993) One step high yield affinity purification of shiga-like toxin II variants and quantitation using enzyme linked immunosorbent assays. Microb Pathog 14:57-66
Acheson, D W (1992) Enterotoxins in acute infective diarrhoea. J Infect 24:225-45

Showing the most recent 10 out of 28 publications